98547760
May 13, 2024
Stem cells for research purposes; biochemicals, namely, antibodies for in vitro scientific or research use; biochemicals, namely, decoy receptors for in vitro scientific or research use
ChemicalsStem cell-derived drug therapies for pharmaceutical purposes to treat of a wide range of diseases; stem cell-derived therapeutic preparations; stem cells for therapeutic treatment of a wide range of diseases; pharmaceutical preparations as CD47 antagonists, integrin-associated proteins (IAP), and CD47 glycoproteins; monoclonal antibodies for medical purposes; monoclonal antibodies for use to suppress immune responses that lead to rejection of stem cell and organ transplants
PharmaceuticalsResearch and development services relating to bone marrow, stem cell, and organ transplantation; research and development in the field of stem cell therapies; research and development relating to bone marrow, stem-cell, and organ transplantation; research and development relating to pharmaceutical preparations as CD47 antagonists, integrin-associated proteins (IAP), and CD47 glycoproteins; research and development services in the field of antibodies; research and development relating to using monoclonal antibodies to suppress immune responses that lead to rejection of stem cell and organ transplants
Computer and Scientific